Thermo Fisher Scientific | TMO - Stock


Thermo Fisher Scientific reported $5.5B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Agilent USD 1.09B 30M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Bio Techne USD 201.18M 4.27M Mar/2026
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
Boston Scientific USD 3.12B 174M Mar/2026
Bruker USD 1.12B 26.9M Mar/2026
Charles River Laboratories USD 359.72M 60.62M Mar/2026
Danaher USD 2.61B 119M Mar/2026
Dentsply International USD 659M 17M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
General Electric Aerospace USD 12.37B 499M Mar/2026
Henry Schein USD 2.01B 12M Mar/2026
Illumina USD 611M 47M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
Laboratory Of America USD 497.7M 37M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Mettler Toledo International USD 404.83M 17.6M Mar/2026
Myriad Genetics USD 27.9M 2.7M Mar/2026
Olympus JPY 208.61B 5.07B Sep/2025
OraSure Technologies USD 30.31M 753K Mar/2026
Quest Diagnostics USD 225M 36M Mar/2026
Repligen USD 179.26M 8.8M Mar/2026
Revvity USD 387.5M 8.01M Mar/2026
Stryker USD 5.42B 109M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 21.42M 870K Mar/2026
Waters USD 1.5B 923.63M Mar/2026
Zimmer Biomet Holdings USD 2.25B 39.6M Mar/2026